{
    "output": {
        "input_text": "PET-CT Whole BodyStaging of known non-small cell lung cancerFindings:\nLung Mass: Hypermetabolic mass in the left upper lobe, SUV max 12.5, consistent with known primary tumor.\nMediastinal Lymph Nodes: Hypermetabolic lymph nodes in the subcarinal region (SUV max 6.8), suggestive of metastatic involvement.\nDistant Metastasis: No hypermetabolic lesions identified in the liver, adrenal glands, bones, or brain to suggest distant metastases.\nBackground Activity: Physiological tracer uptake in other organs.\n\nImpression:\nHypermetabolic primary lung tumor in the left upper lobe.\nSuspicious mediastinal lymph nodes, likely metastatic.\nNo evidence of distant metastatic disease.",
        "keywords": [
            "P",
            "##ET",
            "-",
            "CT Whole Body",
            "##S",
            "##tag",
            "##ing of",
            "known",
            "non -",
            "small cell lung cancer",
            "##Findings : Lung",
            "Mass",
            ": Hyper",
            "##met",
            "##ab",
            "##olic mass",
            "in the left upper lobe",
            ",",
            "SUV ma",
            "##x",
            "12.",
            "5",
            ", consistent with",
            "known",
            "primary tumor. Mediastinal L",
            "##ymph",
            "Nodes : Hyper",
            "##met",
            "##abolic l",
            "##ymph",
            "nodes in the subcarinal region",
            "(",
            "SUV ma",
            "##x",
            "6.",
            "8",
            "), suggestive of metastatic",
            "involvement",
            ". Distant",
            "Metastasis",
            ":",
            "No",
            "hyper",
            "##metabolic",
            "lesions identified in the liver, adrenal glands, bones, or brain to suggest distant metastases.",
            "Background Activity",
            ": Physiological trace",
            "##r",
            "uptake in other organs. I",
            "##mpression",
            ": H",
            "##ypermet",
            "##ab",
            "##olic primary lung tumor",
            "in the left upper lobe.",
            "Suspicious",
            "mediastinal l",
            "##ymph",
            "nodes, likely metastatic. No evidence of distant metastatic disease",
            "."
        ],
        "text": "```json\n{\n  \"terms\": [\n    {\n      \"term\": \"PET-CT\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"A type of medical imaging test that combines Positron Emission Tomography (PET) and Computed Tomography (CT) scans to produce detailed images of the body's internal structures.\",\n      \"relevance\": \"Used for whole-body staging of cancer, particularly non-small cell lung cancer.\",\n      \"relation\": \"The report uses PET-CT to evaluate the extent of cancer spread in the patient.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"Whole Body\",\n      \"category\": \"Imaging finding\",\n      \"explanation\": \"Refers to a comprehensive examination of the entire body, typically performed using imaging modalities like PET-CT or MRI.\",\n      \"relevance\": \"Indicates that the imaging test was conducted on the whole body rather than a specific region.\",\n      \"relation\": \"The report provides findings from the whole-body staging, including lung mass, mediastinal lymph nodes, and distant metastasis.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"non-small cell lung cancer\",\n      \"category\": \"Medical condition\",\n      \"explanation\": \"A type of lung cancer that accounts for about 80-85% of all lung cancers, characterized by the growth of abnormal cells in the lungs.\",\n      \"relevance\": \"The report is focused on staging this specific type of cancer using PET-CT imaging.\",\n      \"relation\": \"The findings and impression are related to the assessment of non-small cell lung cancer spread within the patient.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"Lung Mass\",\n      \"category\": \"Imaging finding\",\n      \"explanation\": \"A hypermetabolic mass in the left upper lobe, as detected by PET-CT imaging, consistent with known primary tumor characteristics.\",\n      \"relevance\": \"Indicates a significant change or abnormality within the lung tissue, potentially indicative of cancer growth.\",\n      \"relation\": \"The report's impression mentions the presence of a hypermetabolic primary lung tumor in the left upper lobe.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"Hypermetabolic\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Describes an area or structure that is excessively active, as measured by PET-CT imaging, often indicative of abnormal cell growth or disease activity.\",\n      \"relevance\": \"Used to describe the mass in the left upper lobe and mediastinal lymph nodes, suggesting potential cancer involvement.\",\n      \"relation\": \"The report's findings include hypermetabolic masses and lymph nodes, which are suspicious for metastatic disease.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"Mediastinal Lymph Nodes\",\n      \"category\": \"Anatomical structure\",\n      \"explanation\": \"Lymph nodes located in the mediastinum (the central part of the chest cavity), which play a crucial role in filtering lymph fluid and detecting cancer spread.\",\n      \"relevance\": \"The report mentions hypermetabolic mediastinal lymph nodes, suggestive of metastatic involvement.\",\n      \"relation\": \"The findings include suspicious mediastinal lymph nodes, likely indicative of cancer spread.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"Distant Metastasis\",\n      \"category\": \"Medical condition\",\n      \"explanation\": \"Refers to the spread of cancer from its primary site to other parts of the body, often indicating advanced disease.\",\n      \"relevance\": \"The report states that no hypermetabolic lesions were identified in distant organs, suggesting no evidence of metastatic disease.\",\n      \"relation\": \"The findings and impression are related to the assessment of distant metastasis within the patient.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"SUV\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"A measure used in PET-CT imaging to quantify the uptake of a radiotracer by tissues, helping to differentiate between normal and abnormal activity.\",\n      \"relevance\": \"Used to describe the maximum standardized uptake value (SUV max) for the lung mass and mediastinal lymph nodes.\",\n      \"relation\": \"The report provides SUV values for the hypermetabolic masses and lymph nodes, which aid in evaluating their potential significance.\",\n      \"subterm\": null\n    },\n    {\n      \"term\": \"Background Activity\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Refers to the normal physiological uptake of a radiotracer by tissues outside the area of interest, used as a reference for interpreting PET-CT findings.\",\n      \"relevance\": \"Indicates that the report takes into account normal physiological tracer uptake in other organs when evaluating PET-CT findings.\",\n      \"relation\": \"The report mentions background activity to provide context for the interpretation of hypermetabolic masses and lymph nodes.\",\n      \"subterm\": null\n    }\n  ]\n}\n```\n\nNote: I've used a consistent format throughout the terms array, providing key information about each term. The subterm field is empty because there are no nested terms in this analysis."
    }
}